Our History

Phronetik was founded by Dr. Tania M. Martin-Mercado, MS, MPH ("Dr. Tania") to bridge the gap between health data and personalized care. Motivated by unanswered questions about disease risk beyond family history and lifestyle, she set out to translate complex genetic insights into actionable health solutions. Without external funding or venture capital, Phronetik started with modest roots and has since grown into a leader in precision health.

​

Today, Phronetik provides clinical trial support, genomic sequencing, and genetic counseling, empowering patients, clinicians, and researchers. Committed to innovation and inclusivity, the company integrates diversity, equity, and inclusion (DEI) into its operations, ensuring transparent and impactful research. Through strategic partnerships and an adaptive approach, Phronetik continues to drive advancements in precision medicine, improving health outcomes for all.